The ethics of genome editing in the clinic: A dose of realism for healthcare leaders

Authors

Tania M. Bubela, University of Alberta, CanadaFollow
Yael Mansour, University of Alberta, Canada
Dianne Nicol, University of Tasmania, Australia

Document Type

Review Article

Department

Office of the Provost

Abstract

Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethical and societal issues raised by these technologies, including their use in preclinical research, their potential to address mutations in somatic cells, and their potential to make germ line alterations that may be passed to subsequent generations. We call for a proportionate response from health leaders based on a realistic assessment of benefits, risks, and timelines for clinical translation.

Comments

This work was published before Tania joined Aga Khan University.

Publication (Name of Journal)

Healthcare Management Forum

DOI

10.1177/0840470416689313

Recommended Citation

Bubela, T. M., Mansour, Y., Nicol, D. (2017). The ethics of genome editing in the clinic: A dose of realism for healthcare leaders. Healthcare Management Forum, 30(3), 159-163.
Available at: https://ecommons.aku.edu/provost_office/747